| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 254,652 | 267,336 | 251,615 | 258,385 | | Cost of Revenue |
-
|
-
|
-
| 46,126 | | | Gross Profit | 254,652 | 267,336 | 251,615 | 212,259 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,633 | 66,137 | 66,667 | 18,773 | | Non Recurring | 116,971 | 5,906 |
-
| 11,235 | | Others | 82,175 | 79,606 | 80,537 | 80,712 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (13,127) | 115,687 | 104,411 | 101,539 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39,962 | 28,732 | 24,333 | 28,374 | | Earnings Before Interest And Taxes | 26,835 | 144,419 | 128,744 | 129,913 | | Interest Expense | 74,039 | 75,340 | 76,674 | 83,348 | | Income Before Tax | (47,204) | 69,079 | 52,070 | 46,565 | | Income Tax Expense | (350) | 841 | 915 | (93) | | Minority Interest |
-
|
-
|
-
| (4,208) | | | | Net Income From Continuing Ops | (45,526) | 69,365 | 50,693 | 42,040 | | | Non-recurring Events | | Discontinued Operations | 2,306 | 31,813 | 2,016 | (1,669) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (43,220) | 101,178 | 52,709 | 40,371 | | Preferred Stock And Other Adjustments | 2,970 | (9,394) | (9,424) | (5,282) | | | Net Income Applicable To Common Shares | ($52,397) | $91,784 | $43,285 | $35,089 |
|
0.29% Nasdaq 
Income Statement
